Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia.
Sugita M, Yamazaki T, Alhomoud M, Martinet J, Latouche JB, Golden E, Boyer O, Van Besien K, Formenti SC, Galluzzi L, Guzman ML. Sugita M, et al. Among authors: latouche jb. Cell Death Dis. 2023 May 4;14(5):305. doi: 10.1038/s41419-023-05829-6. Cell Death Dis. 2023. PMID: 37142568 Free PMC article.
Case report: CAR-T cell therapy-induced cardiac tamponade.
Sarfati S, Eugène Norbert M, Hérault A, Giry M, Makké J, Grall M, Savouré A, Camus V, Alani M, Tamion F, Latouche JB, Girault C. Sarfati S, et al. Among authors: latouche jb. Front Cardiovasc Med. 2023 Mar 20;10:1132503. doi: 10.3389/fcvm.2023.1132503. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37020516 Free PMC article.
Generation of Pure Highly Functional Human Anti-Tumor Specific Cytotoxic T Lymphocytes With Stem Cell-Like Memory Features for Melanoma Immunotherapy.
Hamieh M, Chatillon JF, Dupel E, Bayeux F, Fauquembergue E, Maby P, Drouet A, Duval-Modeste AB, Adriouch S, Boyer O, Latouche JB. Hamieh M, et al. Among authors: latouche jb. Front Immunol. 2021 Sep 8;12:674276. doi: 10.3389/fimmu.2021.674276. eCollection 2021. Front Immunol. 2021. PMID: 34566953 Free PMC article.
Kidney Transplant T Cell-Mediated Rejection Occurring After Anti-CD19 CAR T-Cell Therapy for Refractory Aggressive Burkitt-like Lymphoma With 11q Aberration: A Case Report.
de Nattes T, Camus V, François A, Dallet G, Ferrand C, Guerrot D, Lemoine M, Morin F, Thieblemont C, Veresezan EL, Candon S, Latouche JB, Bertrand D. de Nattes T, et al. Among authors: latouche jb. Am J Kidney Dis. 2022 May;79(5):760-764. doi: 10.1053/j.ajkd.2021.07.012. Epub 2021 Aug 27. Am J Kidney Dis. 2022. PMID: 34461166
[Immunomonitoring of patients treated with CAR-T cells for hematological malignancy: Guidelines from the CARTi group and the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Rubio MT, Varlet P, Allain V, Ballot C, Cuffel A, Deschamps M, Ferrand C, Foguenne J, Forcade E, Huynh A, Guihot A, Latouche JB, Lemarie C, Martinroche G, Morin F, Nguyen S, Schmit K, Servais S, Simonetta F, Yakoub-Agha I, Caillat Zucman S. Rubio MT, et al. Among authors: latouche jb. Bull Cancer. 2021 Dec;108(12S):S53-S64. doi: 10.1016/j.bulcan.2021.04.008. Epub 2021 Jul 9. Bull Cancer. 2021. PMID: 34253335 French.
Presence of T cells directed against CD20-derived peptides in healthy individuals and lymphoma patients.
Milcent B, Josseaume N, Riller Q, Giglioli I, Rabia E, Deligne C, Latouche JB, Hamieh M, Couture A, Toutirais O, Lone YC, Jeger-Madiot R, Graff-Dubois S, Amorim S, Loiseau P, Toubert A, Brice P, Thieblemont C, Teillaud JL, Sibéril S. Milcent B, et al. Among authors: latouche jb. Cancer Immunol Immunother. 2019 Oct;68(10):1561-1572. doi: 10.1007/s00262-019-02389-7. Epub 2019 Sep 7. Cancer Immunol Immunother. 2019. PMID: 31494742 Free PMC article.
Cancer vaccines: designing artificial synthetic long peptides to improve presentation of class I and class II T cell epitopes by dendritic cells.
Rabu C, Rangan L, Florenceau L, Fortun A, Charpentier M, Dupré E, Paolini L, Beauvillain C, Dupel E, Latouche JB, Adotevi O, Labarrière N, Lang F. Rabu C, et al. Among authors: latouche jb. Oncoimmunology. 2019 Jan 17;8(4):e1560919. doi: 10.1080/2162402X.2018.1560919. eCollection 2019. Oncoimmunology. 2019. PMID: 30906653 Free PMC article.
The ADAMTS131239-1253 peptide is a dominant HLA-DR1-restricted CD4+ T-cell epitope.
Gilardin L, Delignat S, Peyron I, Ing M, Lone YC, Gangadharan B, Michard B, Kherabi Y, Sharma M, Pashov A, Latouche JB, Hamieh M, Toutirais O, Loiseau P, Galicier L, Veyradier A, Kaveri S, Maillère B, Coppo P, Lacroix-Desmazes S. Gilardin L, et al. Among authors: latouche jb. Haematologica. 2017 Nov;102(11):1833-1841. doi: 10.3324/haematol.2015.136671. Epub 2017 Jul 27. Haematologica. 2017. PMID: 28751567 Free PMC article.
46 results